10-K
XBRL
ANNUAL REPORT
- Company
- ORAMED PHARMACEUTICALS INC.
- Filed
- November 25, 2015
- Period of Report
- August 31, 2015
- Accession Number
- 0001213900-15-009096
A 10-K is a company's comprehensive annual report, required by the SEC. It includes audited financial statements, a description of the business, risk factors, and management's discussion of results. Learn more about 10-K filings →